Skip to main content

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

AIM holding history

AIM ImmunoTech Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AIM overviewAll 13F holders of AIMFull Q4 2025 holdings

Shares (Q4 2025)
17,502
Value
$19.8K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of AIM by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 202517,502$19.8K<0.1%00.0%UnchangedHolders
Q3 202517,502$48.0K<0.1%+17,502NewHolders
Q2 20250$00.0%−24,443−100.0%Sold outConverted for a 1-for-100 splitHolders
Q1 20252,444,319$298.2K<0.1%+455,615+22.9%AddedHolders
Q4 20241,988,704$393.8K<0.1%00.0%UnchangedHolders
Q3 20241,988,704$537.0K<0.1%00.0%UnchangedHolders
Q2 20241,988,704$741.2K<0.1%00.0%UnchangedHolders
Q1 20241,988,704$936.7K<0.1%00.0%UnchangedHolders
Q4 20231,988,704$874.8K<0.1%00.0%UnchangedHolders
Q3 20231,988,704$904.9K<0.1%00.0%UnchangedHolders
Q2 20231,988,704$1.33M<0.1%00.0%UnchangedHolders
Q1 20231,988,704$855.1K<0.1%00.0%UnchangedHolders
Q4 20221,988,704$620.3K<0.1%+1,109+0.1%AddedHolders
Q3 20221,987,595$1.16M<0.1%00.0%UnchangedHolders
Q2 20221,987,595$1.55M<0.1%00.0%UnchangedHolders
Q1 20221,987,595$2.11M<0.1%−12,690−0.6%ReducedHolders
Q4 20212,000,285$1.84M<0.1%−2,571−0.1%ReducedHolders
Q3 20212,002,856$4.05M<0.1%+9,700+0.5%AddedHolders
Q2 20211,993,156$4.29M<0.1%+66,757+3.5%AddedHolders
Q1 20211,926,399$4.37M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.